Pathogen lipid membrane (PLM)

The pathogen lipid membrane serves as the primary semi-permeable barrier separating the microbial interior from the external environment, playing a critical role in maintaining ion gradients and protecting the organism from osmotic stress. In bacteria, these membranes are often characterized by a high proportion of negatively charged phospholipids and unique components such as lipopolysaccharides (LPS) or lipoteichoic acids, while fungal membranes contain ergosterol instead of the cholesterol found in mammalian cells. These biochemical differences allow for the development of therapeutic agents that selectively target the pathogen. Many antimicrobial peptides and lipopeptide antibiotics exploit these differences to bind and insert into the membrane, leading to pore formation, depolarization, and rapid cell death. Because the membrane is essential for viability and metabolic activity, it remains a highly effective target for treating multidrug-resistant infections, though the potential for toxicity to host cell membranes remains a primary safety concern for systemically administered drugs.

Other names

Microbial cell membraneBacterial cytoplasmic membraneViral envelopeFungal plasma membrane

Drugs targeting pathogen lipid membranes typically act by disrupting the structural integrity of the bilayer. This occurs through several mechanisms: forming transmembrane pores that allow ion leakage (e.g., Amphotericin B, Gramicidin), binding to specific lipid components like lipopolysaccharides or teichoic acids to cause membrane thinning and depolarization (e.g., Polymyxins, Daptomycin), or sequestering essential sterols like ergosterol to compromise membrane fluidity and function.